ArticleMedical oncology (Northwood, London, England)2013
Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients.
Lu He et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this paperpooled ittrialcites it